14627
post-template-default,single,single-post,postid-14627,single-format-standard,strata-core-1.0.1,strata-child-theme-ver-1.0.0,strata-theme-ver-3.0.3,ajax_fade,page_not_loaded,wpb-js-composer js-comp-ver-6.4.1,vc_responsive

Kadans expands Oxfordshire footprint with two new acquisitions at Abingdon Science Park

09:45 17 August in News, Oxfordshire

Kadans has added two further buildings at Abingdon Science Park, Oxfordshire to its Pan-European science park portfolio. The assets, Monarch House and Penlon House were acquired from two separate private clients. The two buildings sit adjacent to Kadans existing ownership of The Science Quadrant. Monarch House and Penlon House total c.50,000 sq ft. As part of the acquisition Kadans will be renovating Monarch House and providing new, high quality laboratory and office accommodation.

Penlon House is 100% let to world renowned medical device company Penlon. Penlon was established in Oxford in 1943 and develops, manufactures, and exports anaesthesia and other medical products to over ninety countries worldwide. Penlon played a critical role in the covid-19 pandemic response manufacturing is ESO 2 emergency ventilators from its site in Abingdon.

Abingdon Science Park is one of the leading locations in Oxfordshire for science and technology innovation. Set in an attractive, landscaped location to the south of Oxford the park offers a variety of accommodation to suit companies at all stages of their development. Kadans is bringing forward new laboratory and office accommodation on the park to support the needs of growing businesses in Oxfordshire.

“Oxford is the UK’s leading hub for innovation, and its life sciences market continues at a pace with increasing demand from investors. We are extremely pleased to have harnessed this demand, working with our clients to secure the sale of these assets – both of which were off-market transactions. The Kadans team has an opportunity to unlock the additional potential in these buildings and drive forward Oxfordshire’s ambition to support and advance further meaningful connections with real estate and the wider life sciences industry.”

Jon Silversides, Partner, Commercial, Carter Jonas

 

Read more, here.